Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
Coherus’ Acquisition of Surface Oncology
Altria’s US$2.75B Acquisition of NJOY
Arnold & Porter advised Altria Group Inc. on the deal. Altria Group Inc. announced the US$2.75 billion acquisition of e-vapor startup NJOY Holdings Inc. Altria’s purchase of...
Alcon Laboratories’ Acquisition of Kala Pharmaceutical’s Eye Drop Treatments
Arnold & Porter advised Alcon Laboratories, Inc. on the deal. Alcon Laboratories, Inc. (Alcon), the global leader in eye care, announced its acquisition of Kala Pharmaceutical’s commercial...